viral entry inhibitor
This page covers all viral entry inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SARS-CoV-2 virus.
Targets
Marketed (1)
- Raxtozinameran 6 months to 4 years of age · Pfizer · Infectious Disease